Fred Aslan, CEO: Artiva Biotherapeutics ARTV Sell · Filed 05/19

Trade details

Type: Insider sale
Amount: $244,315.16
Shares · price: 27,116 sh · $9.01 a share
Held after: 1,535,082 sh
Stock: Artiva Biotherapeutics ARTV
Person: Fred AslanCEO
Trade date: 26/05/19
Filed: 26/05/19
Days to filing: 0 days

Sold 1.7% of holdings

Share of holding sold: 1.7%

Artiva Biotherapeutics trades, last 26 weeks

What else happened in Artiva Biotherapeutics around then

Filed or reported within 30 days of the trade day · 04/19~06/18

Fred Aslan's recent trades

Fred AslanCEO
Planned sale10b5-1 planArtiva Biotherapeutics
Planned sale10b5-1 plan
Artiva Biotherapeutics
ARTV
$262.2K
23,429 sh
$262.2K
Filed 09/08
Traded 09/08
Fred AslanCEO
Planned saleArtiva Biotherapeutics
Planned sale
Artiva Biotherapeutics
ARTV
$258.2K
28,000 sh
$258.2K
Filed 05/18
Traded 05/18
Fred AslanPresident and CEO
Sell10b5-1 planArtiva Biotherapeutics
Sell10b5-1 plan
Artiva Biotherapeutics
ARTV
$19.1K
3,187 sh
$19.1K
Filed 25/12/15
Traded 25/12/15
Fred AslanCEO
Planned sale10b5-1 planArtiva Biotherapeutics
Planned sale10b5-1 plan
Artiva Biotherapeutics
ARTV
$42.1K
12,749 sh
$42.1K
Filed 25/12/15
Traded 25/12/15
Fred AslanPresident and CEO
Sell10b5-1 planArtiva Biotherapeutics
Sell10b5-1 plan
Artiva Biotherapeutics
ARTV
$21.5K
6,375 sh
$21.5K
Filed 25/11/17
Traded 25/11/17